Skip to main content
Erschienen in: International Urogynecology Journal 9/2008

01.09.2008 | Original Article

Predicting detrusor overactivity using a physician-based scoring system

verfasst von: Maria Vella, Dudley Robinson, Linda Cardozo, Sushma Srikrishna, Rufus Cartwright

Erschienen in: International Urogynecology Journal | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Women with lower urinary tract symptoms (LUTS) commonly present to primary care. Management is often based on a symptomatic diagnosis alone although LUTS correlate with urodynamic diagnosis in 65% of cases. The aim of this study was to develop a scoring system to discriminate between the symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB). Physicians completed a specially developed questionnaire for all women complaining of LUTS. Women then underwent videocystourethrography. A scoring system based on the likelihood of each symptom for DO was developed using odds ratios and 95% confidence intervals (CI). This scoring system was subsequently used to discriminate those women with OAB from those with SUI. One hundred seventy one women were recruited to the study. This scoring system had a sensitivity of 79%, a specificity of 78% and a positive predictive value of 73% to identify detrusor overactivity (DO) This new OAB scoring system may be used in primary care to help discriminate between USI and DO.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed
2.
Zurück zum Zitat Abrams P, Cardozo L, Fall M et al (2002) The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178PubMedCrossRef Abrams P, Cardozo L, Fall M et al (2002) The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178PubMedCrossRef
3.
Zurück zum Zitat Andersson K-E (1997) The overactive bladder: pharmacologic basis of drug treatment. Urology 50(6A Suppl):74–84PubMedCrossRef Andersson K-E (1997) The overactive bladder: pharmacologic basis of drug treatment. Urology 50(6A Suppl):74–84PubMedCrossRef
4.
Zurück zum Zitat Jarvis GJ, Hall S, Stamp S, Miller DR, Johnson A (1980) An assessment of urodynamic examination in incontinent women. Br J Obstet Gynaecol 87(10):893–896 OctPubMed Jarvis GJ, Hall S, Stamp S, Miller DR, Johnson A (1980) An assessment of urodynamic examination in incontinent women. Br J Obstet Gynaecol 87(10):893–896 OctPubMed
5.
Zurück zum Zitat National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. October 2006 National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. October 2006
6.
Zurück zum Zitat Milson I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int 87(9):760–766CrossRef Milson I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int 87(9):760–766CrossRef
7.
Zurück zum Zitat Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World Journal of Urology 20(6):327–336PubMed Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World Journal of Urology 20(6):327–336PubMed
8.
Zurück zum Zitat Graham CA, Mallett VT (2001) Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 185(1):116–120 JulPubMedCrossRef Graham CA, Mallett VT (2001) Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 185(1):116–120 JulPubMedCrossRef
9.
Zurück zum Zitat Langer R, Lipshitz Y, Halperin R et al (2001) Long term follow up after Burch colposuspension for urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunction 12:323–326 discussion 326–7CrossRef Langer R, Lipshitz Y, Halperin R et al (2001) Long term follow up after Burch colposuspension for urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunction 12:323–326 discussion 326–7CrossRef
10.
Zurück zum Zitat Ahlberg J, Edlund C, Wikkelso C et al (2002) Neurological signs are common in patients with urodynamically verified “idiopathic”bladder overactivity. Neurourol Urodyn 21(1):65–70PubMedCrossRef Ahlberg J, Edlund C, Wikkelso C et al (2002) Neurological signs are common in patients with urodynamically verified “idiopathic”bladder overactivity. Neurourol Urodyn 21(1):65–70PubMedCrossRef
11.
Zurück zum Zitat Shafer W, Abrams P, Liao L et al (2002) The International Continence Society. Neurourol Urodyn 21(3):261–274CrossRef Shafer W, Abrams P, Liao L et al (2002) The International Continence Society. Neurourol Urodyn 21(3):261–274CrossRef
12.
13.
Zurück zum Zitat Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms. Neurourol Urodyn 22(4):105–108PubMedCrossRef Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms. Neurourol Urodyn 22(4):105–108PubMedCrossRef
14.
Zurück zum Zitat Kelleher CJ, Cardozo L, Khullar V, Salvatore S (1997) A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104(9):988–993 SepPubMed Kelleher CJ, Cardozo L, Khullar V, Salvatore S (1997) A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104(9):988–993 SepPubMed
15.
Zurück zum Zitat Duckett J, Vella M, Kavalakuntla G, Basu M (2007) Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 114(5):543–547 MayPubMedCrossRef Duckett J, Vella M, Kavalakuntla G, Basu M (2007) Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 114(5):543–547 MayPubMedCrossRef
16.
Zurück zum Zitat Hashim H, Abrams P (2004) Do symptoms of overactive bladder predict urodynamic detrusor overactivity? Neurourol Urodyn 23:484 Hashim H, Abrams P (2004) Do symptoms of overactive bladder predict urodynamic detrusor overactivity? Neurourol Urodyn 23:484
Metadaten
Titel
Predicting detrusor overactivity using a physician-based scoring system
verfasst von
Maria Vella
Dudley Robinson
Linda Cardozo
Sushma Srikrishna
Rufus Cartwright
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 9/2008
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-008-0607-x

Weitere Artikel der Ausgabe 9/2008

International Urogynecology Journal 9/2008 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.